Vaccines targeting novel cancer-associated antigens frequently expressed in head and neck cancer enhance the efficacy of checkpoint inhibitor
HPV-independent head and neck squamous cell carcinoma (HNSCC) is a common cancer globally. The overall response rate to anti-PD1 checkpoint inhibitors (CPIs) in HNSCC is similar to 16%. One major factor influencing the effectiveness of CPI is the level of tumor infiltrating T cells (TILs). Convertin...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Frontiers Media
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/34676/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|